Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar Baldpate12ga (49.09) Submitted: 12/18/2006 9:58:48 PM : Outperform Start Price: $13.95 ENZ Score: -84.95

12/18/06 from Red Herring-- Life sciences firm Enzo Biochem, which launched a patent war by claiming that it invented a technique central to DNA sequencing, has raised $43.1 million by selling stock to institutional investors.

Featured Broker Partners


Advertisement